首页 > 市场调查报告书 > 製药

药物开发开发业务受託机关

市场调查报告书

商品编码

1672737

医疗保健 CMO 市场（按服务类型和地区划分）

Healthcare CMO Market, By Service Type, By Geography

出版日期: 2025年02月19日 | 出版商:

Coherent Market Insights | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球医疗保健 CMO 市场规模预估为 1,966.1 亿美元，预计到 2032 年将达到 5,201.3 亿美元，2025 年至 2032 年的复合年增长率为 14.9%。

报告范围		报告详细信息
基准年	2024	2025 年市场规模	1966.1亿美元
效能资料	2020-2024	预测期	2025-2032
预测期：2025 年至 2032 年复合年增长率	14.90％	2032 年金额预测	5201.3亿美元

图。

全球医疗保健 CMO 市场的成长受到全球对高品质药品日益增长的需求的推动。各种製药和生物技术公司越来越多地将其製造业务外包给受託製造厂商)，以专注于其核心竞争力，例如研发、行销和销售。 CMO 提供端到端製造服务，包括药物开发到临床测试用品、商业製造、包装和监管支援。这使得生物製药製造商能够降低生产成本并以高效的方式遵守严格的监管标准。

市场动态

全球医疗保健 CMO 市场的成长受到学名药和生物仿製药市场的不断扩大、对具有成本效益的製药製造外包解决方案的需求不断增长以及药物开发研发投资不断增加等因素的推动。然而，开发生技药品的复杂性、技术纯熟劳工的短缺以及製造设施的严格监管可能会阻碍市场成长。该市场中的公司有机会挖掘亚太和拉丁美洲的新兴市场，这些市场提供低成本的製造地和熟练的劳动力。主要市场参与企业正在对扩大生产能力、先进技术和监管能力进行大量投资，以加强其服务组合和全球企业发展。

研究的主要特点

本报告对全球医疗保健 CMO 市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数，介绍了全球医疗保健 CMO 市场中主要企业的概况。

研究涉及的主要企业包括 Catalent Inc.、Recipharm AB、Aurobindo Pharma Limited、Jubilant Life Sciences Ltd.、Boehringer Ingelheim GmbH、Lonza Group、Patheon Inc. 等。

本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球医疗保健 CMO 市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

相关人员将透过全球医疗保健 CMO 市场分析中使用的各种策略矩阵更轻鬆地做出决策。

公司简介
- Lonza Group
- Catalent, Inc.
- Thermo Fisher Scientific（Patheon）
- Recipharm AB
- Siegfried Holding AG
- Aenova Group
- Almac Group
- Piramal Pharma Solutions
- Evonik Industries AG
- Famar Health Care Services
- Boehringer Ingelheim
- Consort Medical plc
- Pfizer CentreOne
- Baxter BioPharma Solutions
- Jubilant HollisterStier
- Vetter Pharma International GmbH
- Ajinomoto Bio-Pharma Services
- Fareva Group

第 8 章分析师建议

兴衰
一致的机会地图

第九章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI4622

Global Healthcare Cmo Market is estimated to be valued at USD 196.61 Bn in 2025 and is expected to reach USD 520.13 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.9% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 196.61 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	14.90%	2032 Value Projection:	USD 520.13 Bn

Figure. Healthcare Cmo Market Share (%), By Region 2025

Global healthcare CMO market growth is driven by rising demand for high-quality pharmaceutical products across the world. Various pharmaceutical and biotechnology companies are increasingly outsourcing their manufacturing operations to contract manufacturing organizations, in order to focus on their core competencies of research and development, marketing and sales. The CMOs provide end-to-end manufacturing services right from drug development, clinical trial supplies, commercial manufacturing, packaging and regulatory support. This enables the biopharmaceutical players to reduce manufacturing costs and comply with stringent regulatory norms in a time-efficient manner.

Market Dynamics:

Global healthcare CMO market growth is driven by factors such as rising generic and biosimilar drugs market, growing demand for cost-effective pharmaceutical manufacturing outsourcing solutions, and increasing R&D investment in drug development. However, complexity in developing biological drugs, lack of skilled workforce and stringent regulations for manufacturing facilities can hamper the market growth. The companies in this market have opportunity to tap the emerging markets in Asia Pacific and Latin America, owing to availability of low-cost manufacturing base and skilled labor. Key market players are investing heavily in capacity expansion, advanced technologies and regulatory capabilities to strengthen their service portfolio and global footprint.

Key Features of the Study:

This report provides in-depth analysis of the global healthcare CMO market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global healthcare CMO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Catalent Inc., Recipharm AB, Aurobindo Pharma Limited, Jubilant Life Sciences Ltd., Boehringer Ingelheim GmbH, Lonza Group, and Patheon Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global healthcare CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare CMO market

Detailed Segmentation-

By Service Type
- Pharmaceutical Contract Manufacturing Services
- Active Pharmaceutical Ingredients (API) Manufacturing
- Final Dosage Form (FDF) Manufacturing Packaging
- Medical Device Contract Manufacturing Services
- Outsourcing Design
- Device Manufacturing
- Material Process Services
- Electronic Manufacturing Services
- Finished Products
- Final Goods Assembly
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Lonza Group
- Catalent, Inc.
- Thermo Fisher Scientific (Patheon)
- Recipharm AB
- Siegfried Holding AG
- Aenova Group
- Almac Group
- Piramal Pharma Solutions
- Evonik Industries AG
- Famar Health Care Services
- Boehringer Ingelheim
- Consort Medical plc
- Pfizer CentreOne
- Baxter BioPharma Solutions
- Jubilant HollisterStier
- Vetter Pharma International GmbH
- Ajinomoto Bio-Pharma Services
- Fareva Group

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Service Type
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Healthcare CMO Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Healthcare CMO Market, By Service Type, 2020 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pharmaceutical Contract Manufacturing Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Active Pharmaceutical Ingredients (API) Manufacturing
Final Dosage Form (FDF) Manufacturing Packaging
Medical Device Contract Manufacturing Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Outsourcing Design
Device Manufacturing
Material Process Services
Electronic Manufacturing Services
Finished Products
Final Goods Assembly

6. Global Healthcare CMO Market, By Region, 2020 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Company Profiles
- Lonza Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Catalent, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific (Patheon)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Recipharm AB
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Siegfried Holding AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aenova Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Almac Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Piramal Pharma Solutions
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Evonik Industries AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Famar Health Care Services
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Boehringer Ingelheim
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Consort Medical plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer CentreOne
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Baxter BioPharma Solutions
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Jubilant HollisterStier
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Vetter Pharma International GmbH
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Ajinomoto Bio-Pharma Services
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Fareva Group
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies

8. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

医疗保健 CMO 市场（按服务类型和地区划分）